![Alessandra Decina](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Alessandra Decina
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Rarecells Diagnostics SAS
![]() Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward.
5
| Subsidiary | Packaged Software | 5 |
Rarecells USA, Inc.
![]() Rarecells USA, Inc. Packaged SoftwareTechnology Services Rarecells USA, Inc. is a company dedicated to early cancer detection to save lives. The company is based in New York, NY. The company believes that accurate and early cancer detection has the potential to save millions of lives. Rarecells is developing a prostate cancer test and a multi-cancer test for early cancer diagnosis. The company is currently conducting three clinical studies to evaluate the performance of their dedicated iset-based assay. The company was founded in 2011 by Patrizia Paterlini-Bréchot, who has been the CEO since 2011.
2
| Holding Company | Packaged Software | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alessandra Decina via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
ScreenCell SA
![]() ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France. | Miscellaneous Commercial Services | Founder | |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | ||
Roche Molecular Systems, Inc.
![]() Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
NEOGENOMICS, INC. | Medical/Nursing Services | Director/Board Member | |
Nottingham Trent University | College/University | Undergraduate Degree | |
University of Portsmouth | College/University | Doctorate Degree | |
Alveo Technologies, Inc.
![]() Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Medical Specialties | Director/Board Member | |
IDbyDNA, Inc.
![]() IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Biotechnology | Chief Executive Officer | |
Roche Sequencing Solutions, Inc.
![]() Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | President | |
GENETIC SIGNATURES LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
Global Virus Network
![]() Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Institut Pasteur Korea Research Foundation
![]() Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Biotechnology | Director/Board Member | |
Compagnie Merieux Alliance SAS
![]() Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
Institut Pasteur
![]() Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | President | |
European Personalised Medicine Association | Director/Board Member | ||
Fondation Ophtalmologique Adolphe de Rothschild
![]() Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Fondation Ophtalmologique Adolphe de Rothschild is a specialized hospital in Paris, FR that focuses on treating all pathologies related to the head and neck for both adults and children. The hospital has a pharmacy that ensures the supply of medicines and medical devices. The hospital also has a clinical research service that serves as a one-stop-shop for investigators and industrial or academic partners. The hospital is supported by the Edmond de Rothschild Foundations, which offer a Medical Fellowship program to support talented and promising young practitioners in their hospital-university dynamic. The CEO of the French company is Julien Gottsmann. | Hospital/Nursing Management | Director/Board Member | |
Fondation Mérieux | Investment Trusts/Mutual Funds | Director/Board Member | |
BIOMÉRIEUX | Medical Specialties | Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Hopital Necker-Enfants Malades | Corporate Officer/Principal | ||
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TRANSGENE | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Frankrijk | 11 |
Verenigde Staten | 9 |
Verenigd Koninkrijk | 3 |
Spanje | 2 |
Australië | 2 |
Sectoraal
Health Services | 7 |
Health Technology | 7 |
Commercial Services | 5 |
Consumer Services | 4 |
Miscellaneous | 4 |
Operationeel
Director/Board Member | 19 |
Corporate Officer/Principal | 6 |
President | 6 |
Chief Executive Officer | 4 |
Founder | 3 |
Sterkste connecties
- Beurs
- Insiders
- Alessandra Decina
- Bedrijfsconnecties